Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Jan 29 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: QUICKPULSAR who wrote (756)	8/11/1998 8:58:00 AM
From: FNS	Read Replies (1) of 965

Just getting a chance to catch up CNTO stock data...back from 5 weeks in Italy...found it difficult to get find an availble PC to check in! Anyway, stock seems in downtrend but trying to base in low 30's...ths is a good buy a deadly if negative FDA news holds up Avakine...on the positive side, it looks like the stock can turn around and rally to 42-44, pending positive news on Reopro, retavase, and avakine.... Previous comment regarding "growth" and "competion" scares me...like other products (i.e., techies), revenues and life cycle of current CNTO drugs in pipeline and pending avakine could be impacted easily by by more aggressive competition. Anyone have any real "positive" data to share? Am long, but???? FNS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next